Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Madopar versus placebo with white noise during new word learning
ACTRN12620000809932Phase 4Completed
- Sponsor
- The University of Queensland
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa + benserazide, sponsored by The University of Queensland. Primary endpoints: New word recognition accuracy, New word recall accuracy and 1 more. Started Jun 2020; status: completed.
02
Drugs
levodopa + benserazide
Beyond the preview
Go deeper on ACTRN12620000809932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000809932.